Peripheral Vascular Devices Market

The report "Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031" is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7% from 2026 to 2031.

Browse 380 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on "Peripheral Vascular Devices Market, by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html

Several key factors contribute to the growth of the peripheral vascular devices market. The primary driver is the increasing prevalence of vascular-related diseases, particularly chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as peripheral artery disease (PAD). The aging population, combined with lifestyle-related risk factors such as diabetes, obesity, and hypertension, has led to a rise in these conditions. Additionally, advancements in less-invasive technologies, including drug-eluting stents, balloons, and atherectomy devices, have positively influenced the market. These innovations have resulted in greater patient acceptance and improved procedural safety. The growing awareness within the healthcare sector, along with heightened patient awareness, further supports demand for these devices.

Moreover, the expansion of healthcare facilities in developing countries and enhanced reimbursement policies for peripheral interventions are also contributing factors. Continuous research aimed at developing next-generation devices that offer improved efficacy, durability, and user-friendliness is significantly driving market growth.

By type of angioplasty stent, the drug-eluting stents segment is expected to grow at the highest CAGR during the forecast period.

The increasing incidence of peripheral artery disease (PAD) and diabetes, particularly among the elderly population, is primarily driving the adoption of angioplasty stents in the peripheral vascular devices market. Patients are increasingly opting for less-invasive revascularization treatments. Significant advancements in stent technologies—such as drug-eluting, self-expanding, and covered stents—have greatly improved long-term patency rates, leading to broader clinical adoption. Additionally, the rising preference among physicians for endovascular procedures over traditional open surgery, the growing infrastructure of catheterization labs, and improved reimbursement policies for peripheral interventions are all contributing to rapid market growth.

By catheter, the angiography catheters segment accounted for the largest market share in 2025.

The demand for angiography catheters in the peripheral vascular devices market is primarily driven by the rising incidence of peripheral artery disease and other conditions that require precise imaging for accurate intervention. The rise in minimally invasive endovascular procedures, coupled with the growing use of angiography for treatment planning and post-procedural assessment, is also contributing to this demand. Improvements in catheter design, such as enhanced torque control, flexibility, and radiopacity, have made these procedures more efficient and widely accepted. Furthermore, the expansion of catheterization laboratories, the increasing elderly population, and the provision of interventional vascular care in both developed and developing countries are additional factors contributing to the market's growth.

Based on end user, the ambulatory surgical centers segment is expected to grow at the highest CAGR during the forecast period.

The peripheral vascular devices market is growing as minimally invasive vascular procedures are increasingly adopted and can be safely performed on an outpatient basis. Ambulatory surgical centers (ASCs) offer significant cost benefits, shorter procedure times, quicker patient recovery, and reduced hospital burdens, making them attractive to both healthcare providers and patients. The development of small, user-friendly peripheral vascular devices, such as angioplasty balloons, atherectomy systems, and imaging tools, has enabled complex procedures to be performed effectively in ASC settings. Additionally, favorable reimbursement policies in various regions, physician ownership models, growing patient preferences for same-day discharge, and the rising incidence of Peripheral Artery Disease (PAD), particularly among elderly and diabetic populations, are further accelerating the adoption of ASCs in this market.

North America dominated the global peripheral vascular devices market in 2025.

The growing demand for peripheral vascular devices in the North American market is primarily driven by the high incidence of peripheral artery disease (PAD) as well as the prevalence of related cardiovascular risk factors such as diabetes, obesity, and an aging population. The region benefits from a strong healthcare system, early adoption of advanced minimally invasive technologies, and a significant presence of leading device manufacturers. These companies continually invest in innovation and generate clinical evidence. Factors contributing to market growth include favorable reimbursement policies, increased acceptance of outpatient and ambulatory surgical center-based interventions, and heightened physician awareness. Additionally, stringent regulatory oversight facilitates quicker adoption of proven technologies, while the rising demand for limb-salvage and endovascular procedures also plays a significant role in the expansion of the regional market.

Key Market Players

Some of the prominent players operating in the peripheral vascular devices market include Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Merit Medical Systems (US), Penumbra, Inc. (US), Koninklijke Philips (Netherlands), Stryker (US), Cordis (US), W.L. Gore & Associates (US), Biotronik Stryker (US), Endologix LLC (US), and Cook Medical (US), among others.

Don’t miss out on business opportunities in Keyword. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com